US4193985A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Multiple-units drug dose
Assignee: Alfred Benzon AS
•
Filing: 1978-03-23
•
Granted: 1980-03-18
•
Expires: 1998-03-23
Abstract
Abstract A controlled release multiple-units drug dose is described, which comprises a tablet or a capsule enclosing a plurality of subunits, each containing a therapeutically active agent and being enclosed in an insoluble membrane allowing for diffusion of the juices of the gastrointestinal tract, at least some of the subunits being of increased specific weight as compared with the specific weight of the active agent.
Inventors
- 👤 Helle Bechgaard
- 👤 Arne M. Pedersen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 17:20
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/501; A61K9/14; A61K9/16; A61K9/1605; A61K9/1611; A61K9/5073; A61K9/5078
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
106 words
A controlled release upper-gut retentive gastrointestinal tract transit time increasing multiple-units drug dose, which comprises a tablet or a capsule, enclosing subunits of a therapeutically active agent in the form of 0.3 to 1.7 millimeter balls or pellets, each of which are enclosed in an insoluble dialysis membrane of a cellulose ether or acrylic polymer allowing for diffusion of the juices of the gastrointestinal tract, the specific weight of at least 25% by weight of which subunits has been increased from 1.0 or less to at least 1.4 by means of a physiologically innocuous substance of higher specific weight than that of the therapeutically active agent.
Claim 2
Dependent Claim
106 words
A controlled release upper-gut retentive gastrointestinal tract transit time increasing multiple-units drug dose, which comprises a tablet or a capsule, enclosing subunits of a therapeutically active agent in the form of 0.3 to 1.7 millimeter balls or pellets, each of which are enclosed in an insoluble dialysis membrane of a cellulose ether or acrylic polymer allowing for diffusion of the juices of the gastrointestinal tract, the specific weight of at least 25% by weight of which subunits has been increased from 1.0 or less to at least 1.4 by means of a physiologically innocuous substance of higher specific weight than that of the therapeutically active agent.
Claim 3
Dependent Claim
130 words
A controlled release upper-gut retentive gastrointestinal tract transit time increasing multiple-units drug dose, which comprises a tablet or a capsule, enclosing subunits of a therapeutically active agent in the form of spherical 0.3 to 1.7 millimeter balls or pellets, each of which are enclosed in an insoluble dialysis membrane of ethyl cellulose or acrylic polymer allowing for diffusion of the juices of the gastrointestinal tract, the specific weight of at least 25% by weight of which subunits has been increased to at least 1.4 by means of barium sulfate, zinc oxide, titanium dioxide or ferrum reductum, as a physiologically innocuous substance of higher specific weight than that of the therapeutically active agent, and the other subunits in the drug dose have an otherwise unchanged specific weight of 1.0 or less.
Claim 4
Dependent Claim
130 words
A controlled release upper-gut retentive gastrointestinal tract transit time increasing multiple-units drug dose, which comprises a tablet or a capsule, enclosing subunits of a therapeutically active agent in the form of spherical 0.3 to 1.7 millimeter balls or pellets, each of which are enclosed in an insoluble dialysis membrane of ethyl cellulose or acrylic polymer allowing for diffusion of the juices of the gastrointestinal tract, the specific weight of at least 25% by weight of which subunits has been increased to at least 1.4 by means of barium sulfate, zinc oxide, titanium dioxide or ferrum reductum, as a physiologically innocuous substance of higher specific weight than that of the therapeutically active agent, and the other subunits in the drug dose have an otherwise unchanged specific weight of 1.0 or less.
Claim 5
Dependent Claim
25 words
A drug dose as set forth in claim 2, in which the specific weight of at least some of the subunits is at least 1.6.
Claim 6
Dependent Claim
20 words
A drug dose as set forth in claim 2, in which subunits of different specific weights contain different therapeutic agents.
References Cited (Backward Citations)
US2801203A
Cited
US3056724A
Cited
US3017329A
Cited
US3368944A
Cited
US3444290A
Cited
US3341417A
Cited
JPS4427839B1
Cited
US3592185A
Cited
US3608061A
Cited
JPS4824246B1
Cited
US3775537A
Cited
US3917813A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-03-18 | 1983-09-17 | 1984-03-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-03-18 | 1987-09-17 | 1988-03-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-03-18 | 1991-09-17 | 1992-03-18 | $7700.00 | Window Closed / Lapsed |